Cargando…
Use of Half-Generation PAMAM Dendrimers (G0.5–G3.5) with Carboxylate End-Groups to Improve the DACHPtCl(2) and 5-FU Efficacy as Anticancer Drugs †
The DACHPtCl(2) compound (trans-(R,R)-1,2-diaminocyclohexanedichloroplatinum(II)) is a potent anticancer drug with a broad spectrum of activity and is less toxic than oxaliplatin (trans-l-diaminocyclohexane oxalate platinum II), with which it shares the active metal fragment DACHPt. Nevertheless, du...
Autores principales: | Camacho, Cláudia, Tomás, Helena, Rodrigues, João |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156256/ https://www.ncbi.nlm.nih.gov/pubmed/34069054 http://dx.doi.org/10.3390/molecules26102924 |
Ejemplares similares
-
Selective cytotoxicity of PAMAM G5 core–PAMAM G2.5 shell tecto-dendrimers on melanoma cells
por: Schilrreff, Priscila, et al.
Publicado: (2012) -
Molecular dynamics simulations in drug delivery research: Calcium chelation of G3.5 PAMAM dendrimers
por: Jones, David E., et al.
Publicado: (2016) -
Optimization and In Vivo Toxicity Evaluation of G4.5 Pamam Dendrimer-Risperidone Complexes
por: Prieto, Maria Jimena, et al.
Publicado: (2014) -
In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer
por: Oddone, Natalia, et al.
Publicado: (2016) -
Synthesis, Internalization and Visualization of N-(4-Carbomethoxy) Pyrrolidone Terminated PAMAM [G5:G3-TREN] Tecto(dendrimers) in Mammalian Cells †
por: Studzian, Maciej, et al.
Publicado: (2020)